Switzerland· 69389002
Awiqli FlexTouch 700 E/ml, Injektionslösung im Fertigpen
A insulins and analogues for injection, long-acting product containing insulinum icodecum, registered in Switzerland by Novo Nordisk Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 5 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Insulinum icodecum is registered in 5 of 19 countries.
Countries holding a registration under ATC A10AE (insulins and analogues for injection, long-acting), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Insulinum icodecum · ATC A10AE
5 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- insulinum icodecum
- Manufacturer
- Novo Nordisk Pharma AG
- Country
- Switzerland (CH)
- ATC code
- A10AE
- ATC class
- Insulins and analogues for injection, long-acting
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulinum icodecum in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAWIQLINovo Nordisk A/S, Bagsvaerd
- BelgiumAwiqli 700 U/mlNovo Nordisk
- United StatesAwiqliNovo Nordisk
- CanadaAWIQLINOVO NORDISK CANADA INC
- Japanインスリン イコデク（遺伝子組換え）ノボ ノルディスク ファーマ
- ItalyAWIQLI*1 penna preriempita SC 700 U/ml 1,5 ml + 14 aghiNOVO NORDISK A/S
- IcelandAwiqliNovo Nordisk A/S*
- FinlandAwiqliNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Awiqli
- Norway · Awiqli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfe80d61-d136-4622-8c5e-17fc301924ca GET /v1/drugs/dfe80d61-d136-4622-8c5e-17fc301924ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about insulinum icodecum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.